| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/10/2013 | CN103191330A Traditional Chinese medicine used for treating swelling of limbs of hemiplegic patient |
| 07/10/2013 | CN103191326A Medicine preparation for treating coronary heart diseases |
| 07/10/2013 | CN103191320A Soft garlic oil capsule and preparation method thereof |
| 07/10/2013 | CN103191312A Kidney tonifying and body building medicament |
| 07/10/2013 | CN103191309A Mailuoning granule and preparation method |
| 07/10/2013 | CN103191291A Traditional Chinese medicine composition for treating viral myocarditis |
| 07/10/2013 | CN103191280A Tradtional Chinese medicine for treating angiitis |
| 07/10/2013 | CN103191252A Traditional Chinese medicine preparation for treating coronary disease and preparation method of traditional Chinese medicine preparation |
| 07/10/2013 | CN103191226A Peach seed-containing medicinal composition for treating stroke diseases, and preparation thereof |
| 07/10/2013 | CN103191216A Ginseng-containing medicinal composition for treating stroke diseases, and preparation thereof |
| 07/10/2013 | CN103191210A Traditional Chinese medicine for treating coronary heart diseases |
| 07/10/2013 | CN103191187A Uses of different positions of Salvia miltiorrhiza Bunge and Panax Notoginseng and combinations thereof in smooth muscle cell proliferation inhibition and coronary artery restenosis control |
| 07/10/2013 | CN103191178A Boswellia carteri-containing medicinal composition for treating stroke diseases, and preparation thereof |
| 07/10/2013 | CN103191174A Novel use of eucommia ulmoides chemical component as blood vessel protective agent |
| 07/10/2013 | CN103191153A Muscular amino acid and nucleoside extract and pharmaceutical composition thereof |
| 07/10/2013 | CN103191137A Compound preparation containing aspirin and proton pump inhibitor and preparation method thereof |
| 07/10/2013 | CN103191136A Compound preparation containing aspirin and ilaprazole sodium and preparation method thereof |
| 07/10/2013 | CN103191131A Traditional Chinese medicine raw material as well as preparation and use thereof |
| 07/10/2013 | CN103191130A Traditional Chinese medicine raw material as well as preparation and use thereof |
| 07/10/2013 | CN103191126A Method for preparing irbesartan and hydrochlorothiazide tablets |
| 07/10/2013 | CN103191125A Valsartan and hydrochlorothiazid tablet and preparation method thereof |
| 07/10/2013 | CN103191124A Valsartan and hydrochlorothiazid capsule and preparation method thereof |
| 07/10/2013 | CN103191112A Compound preparation containing atenolol and amlodipine |
| 07/10/2013 | CN103191111A Oral tablet containing atenolol and amlodipine |
| 07/10/2013 | CN103191106A Application of genipin amino acid derivative as NF-kappa B inhibitor |
| 07/10/2013 | CN103191103A Synthetic method of acetaldehyde dehydrogenase activator alda-1, and application of same |
| 07/10/2013 | CN103191089A Novel astaxanthin heath-care wine and preparation method thereof |
| 07/10/2013 | CN103191080A Acetylcysteine effervescent tablet |
| 07/10/2013 | CN103191076A Method for preparing irbesartan tablets |
| 07/10/2013 | CN103191074A Valsartan dispersible tablet and preparation method thereof |
| 07/10/2013 | CN103191073A Amlodipine benzenesulfonate tablet and preparation method thereof |
| 07/10/2013 | CN103191072A Simvastatin tablets and preparation method thereof |
| 07/10/2013 | CN103191071A Irbesartan dispersible tablet and preparation method thereof |
| 07/10/2013 | CN102755289B Argatroban injection for resisting thrombus and preparation method thereof |
| 07/10/2013 | CN102742691B Health-care tea drink with blood pressure lowering effect and preparation method thereof |
| 07/10/2013 | CN102641450B Traditional Chinese medicine for treating hypertension |
| 07/10/2013 | CN102631404B Traditional Chinese medicine composition for treating chest impediment |
| 07/10/2013 | CN102626391B Aliskiren-hydrochlorothiazide drug combination liposome solid preparation |
| 07/10/2013 | CN102579381B Guanidine hydrochloride sustained release preparation and preparation method thereof |
| 07/10/2013 | CN102579368B Metoprolol slow-release microsphere, slow-release medical composition and preparation method of metoprolol slow-release microsphere |
| 07/10/2013 | CN102579320B Citicoline sodium brain-targeting thermosensitive gel and preparation method thereof |
| 07/10/2013 | CN102526469B Compound medicament for rehabilitation after myocardial infarction and preparation method thereof |
| 07/10/2013 | CN102526345B Chinese medicinal composition for treating hypertension |
| 07/10/2013 | CN102488649B 葛根素氯化钠注射液及其制备方法 Puerarin sodium chloride injection and preparation method |
| 07/10/2013 | CN102432670B Silkworm chrysalis protein source dipeptide SS and application thereof |
| 07/10/2013 | CN102373210B MicroRNA (Ribonucleic Acid) relevant to diabetes mellitus endothelial progenitor cell paralysis and application thereof |
| 07/10/2013 | CN102342943B Brand new oral solid medicinal composition and its preparation method |
| 07/10/2013 | CN102319282B Aqueous two-phase extraction method for total flavones in kudzu root |
| 07/10/2013 | CN102283834B Orlisat-containing medicinal composition and application thereof |
| 07/10/2013 | CN102274214B Medicinal use of (E)-N-furanylmethylene-1-benzyl-3-(4-chlorphenyl)-1H-pyrazol-5-carbohydrazide |
| 07/10/2013 | CN102240376B Medicament for treating apoplexy |
| 07/10/2013 | CN102240302B Chinese medicine composition of super gene active peptide |
| 07/10/2013 | CN102145174B Chondroitin sulfate nano-selenium and preparation method thereof |
| 07/10/2013 | CN102030754B Non-viral vector, and preparation method and application thereof |
| 07/10/2013 | CN102008499B NaHS micro-capsule coverage medicinal preparation and preparation method thereof |
| 07/10/2013 | CN101838261B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/10/2013 | CN101768080B Medicinal compound and medicinal use thereof |
| 07/10/2013 | CN101745005B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof |
| 07/10/2013 | CN101744998B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 07/10/2013 | CN101690731B Application of umbilical cord Wharton jelly originated mesenchymal stem cells in heart failure cellular transplantation therapy |
| 07/10/2013 | CN101638383B Quinoline as well as pharmaceutical composition and use thereof |
| 07/10/2013 | CN101591324B Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101591323B Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101516385B Treatment of excessive neovascularization |
| 07/09/2013 | US8481730 Method of synthesis of Bosentan, its polymorphic forms and its salts |
| 07/09/2013 | US8481580 interleukin 1, 12, tumor necrosis factor alpha, and trigger interferon- gamma antagonist; antiinflammatory , antidiabetic agent, autoimmune disorders; active side chain moiety (5-R-hydroxyhexyl) of lisofyllin, greater potency and oral bioavailability than lisofylline |
| 07/09/2013 | US8481562 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/09/2013 | US8481538 Heterocyclic inhibitors of c-Met and uses thereof |
| 07/09/2013 | US8481537 Caspase inhibitors based of pyridazinone scaffold |
| 07/09/2013 | US8481528 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481512 Compositions and methods for modulation of vascular structure and/or function |
| 07/09/2013 | US8481053 Compositions and methods for treating of microbial infections |
| 07/09/2013 | CA2722087C 4-dimethylaminobutyric acid derivatives |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/05/2013 | CA2800946A1 Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same |
| 07/04/2013 | WO2013100630A1 Fixed dose combination formulation comprising losartan, amlodipine and hydrochlorothiazide |
| 07/04/2013 | WO2013100568A1 Phenyl carbamate compounds for use in preventing or treating stroke |
| 07/04/2013 | WO2013098773A1 Crystalline forms of pitavastatin calcium |
| 07/04/2013 | WO2013098764A1 Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof |
| 07/04/2013 | WO2013098763A1 Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof |
| 07/04/2013 | WO2013064672A3 Oxazaphosphorines dosed one time for treating diseases |
| 07/04/2013 | WO2013061105A3 Glycogen phosphorylase inhibitors |
| 07/04/2013 | WO2013057579A3 Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors |
| 07/04/2013 | WO2013055385A3 Methods of treating age related disorders |
| 07/04/2013 | WO2013038195A3 Pharmaceutical nanoparticle compositions |
| 07/04/2013 | US20130172349 Inhibitors of phosphatidylinositol 3-kinase |
| 07/04/2013 | US20130172300 New hormonal composition and its use |
| 07/04/2013 | DE112010005848T5 Amidverbindungen Amide compounds |
| 07/04/2013 | CA2855919A1 Diphenylmethyl piperazine derivative and pharmaceutical composition using same |
| 07/03/2013 | EP2610249A1 Pluripotent stem cell cardiomyocyte differentiation-promoting agent |
| 07/03/2013 | EP2609925A2 Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved |
| 07/03/2013 | EP2609218A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 07/03/2013 | EP2609093A1 Salt compound |
| 07/03/2013 | EP2609092A1 Oxadiazole inhibitors of leukotriene production |
| 07/03/2013 | EP2609078A1 Hydroxamate-based inhibitors of deacetylases |
| 07/03/2013 | EP2608784A1 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| 07/03/2013 | EP2608777A2 Compositions and methods for cardiac therapy |